KR101162710B1 - 도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물 - Google Patents

도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물 Download PDF

Info

Publication number
KR101162710B1
KR101162710B1 KR1020090100092A KR20090100092A KR101162710B1 KR 101162710 B1 KR101162710 B1 KR 101162710B1 KR 1020090100092 A KR1020090100092 A KR 1020090100092A KR 20090100092 A KR20090100092 A KR 20090100092A KR 101162710 B1 KR101162710 B1 KR 101162710B1
Authority
KR
South Korea
Prior art keywords
bellflower
hepatitis
extract
pharmaceutical composition
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020090100092A
Other languages
English (en)
Korean (ko)
Other versions
KR20100086923A (ko
Inventor
김종우
이상욱
박상진
신중철
임종환
양재원
Original Assignee
(주) 비엔씨바이오팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 비엔씨바이오팜 filed Critical (주) 비엔씨바이오팜
Priority to EP10733644A priority Critical patent/EP2389185A2/en
Priority to US13/143,895 priority patent/US20110274656A1/en
Priority to JP2011547776A priority patent/JP2012515773A/ja
Priority to AU2010207093A priority patent/AU2010207093A1/en
Priority to CA2748942A priority patent/CA2748942A1/en
Priority to PCT/KR2010/000376 priority patent/WO2010085091A2/en
Priority to CN2010800037472A priority patent/CN102264378A/zh
Publication of KR20100086923A publication Critical patent/KR20100086923A/ko
Application granted granted Critical
Publication of KR101162710B1 publication Critical patent/KR101162710B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10F—INORGANIC SEMICONDUCTOR DEVICES SENSITIVE TO INFRARED RADIATION, LIGHT, ELECTROMAGNETIC RADIATION OF SHORTER WAVELENGTH OR CORPUSCULAR RADIATION
    • H10F10/00—Individual photovoltaic cells, e.g. solar cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00—Energy generation through renewable energy sources
    • Y02E10/50—Photovoltaic [PV] energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
KR1020090100092A 2009-01-23 2009-10-21 도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물 Expired - Fee Related KR101162710B1 (ko)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US13/143,895 US20110274656A1 (en) 2009-01-23 2010-01-21 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
JP2011547776A JP2012515773A (ja) 2009-01-23 2010-01-21 キキョウ抽出物又はキキョウサポニン化合物を含むｃ型肝炎の予防又は治療用薬学的組成物
AU2010207093A AU2010207093A1 (en) 2009-01-23 2010-01-21 Pharmaceutical composition for preventing or treating Hepatitis C, comprising the roots extract of Platycodon grandiflorum or Platycodon grandiflorum saponin components
CA2748942A CA2748942A1 (en) 2009-01-23 2010-01-21 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
EP10733644A EP2389185A2 (en) 2009-01-23 2010-01-21 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
PCT/KR2010/000376 WO2010085091A2 (en) 2009-01-23 2010-01-21 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
CN2010800037472A CN102264378A (zh) 2009-01-23 2010-01-21 包含桔梗根提取物或桔梗皂甙组分的用于预防或治疗丙型肝炎的药物组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090006078 2009-01-23
KR1020090006078 2009-01-23

Publications (2)

Publication Number Publication Date
KR20100086923A KR20100086923A (ko) 2010-08-02
KR101162710B1 true KR101162710B1 (ko) 2012-07-05

Family

ID=42753875

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090100092A Expired - Fee Related KR101162710B1 (ko) 2009-01-23 2009-10-21 도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물

Country Status (8)

Country Link
US (1) US20110274656A1 (enExample)
EP (1) EP2389185A2 (enExample)
JP (1) JP2012515773A (enExample)
KR (1) KR101162710B1 (enExample)
CN (1) CN102264378A (enExample)
AU (1) AU2010207093A1 (enExample)
CA (1) CA2748942A1 (enExample)
WO (1) WO2010085091A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014193088A1 (ko) * 2013-05-31 2014-12-04 동국대학교 산학협력단 포도근 추출물 또는 이의 분획물을 유효성분으로 포함하는 c형 간염의 예방 또는 치료용 조성물
KR20160096967A (ko) 2015-02-06 2016-08-17 주식회사 웰파이토 도라지 발효물을 유효성분으로 포함하는 기관지질환, 면역증강 및 항비만 예방 효능의 건강차 조성물
US10258662B2 (en) 2013-05-31 2019-04-16 Dongguk University Industry-Academic Cooperation Foundation Composition for preventing or treating hepatitis C including vitidis vinferae radix extract or fraction thereof as active ingredient

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101251589B1 (ko) * 2012-09-27 2013-04-08 한국화학연구원 도라지 또는 도라지 추출물로부터의 순도 및 유효 사포닌 함량이 증가된 조사포닌 조성물의 제조방법
CN103768078B (zh) * 2012-10-22 2019-02-05 北京大学 三萜衍生物及其抗流感用途
JP6095591B2 (ja) * 2014-02-12 2017-03-15 株式会社アンチエイジング・プロ 山芋抽出物の製造方法
KR101880934B1 (ko) 2017-09-14 2018-07-23 주식회사 아오스 도라지에서 추출된 도라지 사포닌 농축물을 함유하는 약학적 조성물의 제조방법
WO2020085799A1 (ko) * 2018-10-23 2020-04-30 주식회사 온사이언스 도라지 사포닌을 포함하는 표준화된 도라지 추출물 또는 막분리 도라지 사포닌 추출물을 함유하는 간질환의 예방 또는 치료용 약학적 조성물 및 간기능 개선용 건강기능식품
CN111394266B (zh) * 2019-12-03 2023-12-22 延边大学 一种去芹糖桔梗皂苷d的制备方法及其应用
CN110754573A (zh) * 2019-12-04 2020-02-07 金陵科技学院 一种桔梗皂苷d饲料添加剂及其应用、制备方法
CN113116912A (zh) * 2021-06-07 2021-07-16 长春中医药大学 去芹糖桔梗皂苷d在制备预防和/或治疗肝癌药物中的应用
KR102611611B1 (ko) 2023-03-21 2023-12-11 주식회사 아오스 도라지에서 추출된 도라지 사포닌 농축물을 함유하는 약학적 조성물의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005501018A (ja) 2001-06-15 2005-01-13 コリア リサーチ インスティチュート オブ ケミカル テクノロジー キキョウ抽出物の退行性脳疾患の予防および治療、または記憶力増進のための使用
WO2006046674A1 (ja) * 2004-10-25 2006-05-04 Chugai Seiyaku Kabushiki Kaisha Ｃ型肝炎ウイルス感染症の予防および治療剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
KR20030021072A (ko) * 2001-09-05 2003-03-12 주식회사 장생도라지 간 질병의 예방 및 치료용 간장질환용제
CN1397560A (zh) * 2002-08-13 2003-02-19 吉林天药科技股份有限公司 从桔梗中提取桔梗总皂苷和单体桔梗皂苷d的方法及其医药新用途和中药制剂
CN1566137A (zh) * 2003-07-04 2005-01-19 深圳亿胜医药科技发展有限公司 桔梗总皂苷生产工艺
KR100564927B1 (ko) * 2003-09-04 2006-03-30 비타민하우스알앤비티(주) 플라티코딘을 유효성분으로 함유하는 항암제
KR100643877B1 (ko) * 2004-07-19 2006-11-10 주식회사 장생도라지 장생도라지 추출물을 유효성분으로 함유하는 알코올성간질환의 억제, 치료용 약학적 조성물 및 알코올대사촉진용 조성물
KR20050043880A (ko) * 2005-04-27 2005-05-11 김성호 간염억제활성을 갖는 생약 제제 추출물
KR100543354B1 (ko) * 2005-05-17 2006-01-20 김성호 간염억제활성을 갖는 생약재 추출물
JP4794944B2 (ja) * 2005-08-11 2011-10-19 博光 熊田 Ｃ型肝炎に対するインターフェロン／リバビリン併用療法の有効性の判定方法
CN100406467C (zh) * 2006-05-24 2008-07-30 浙江大学 利用弱极性大孔树脂制备桔梗总皂苷提取物的方法及用途
CN101240005A (zh) * 2007-10-29 2008-08-13 吉林农业大学 一种从桔梗中制备桔梗皂苷d的方法及其在抗癌药物中的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005501018A (ja) 2001-06-15 2005-01-13 コリア リサーチ インスティチュート オブ ケミカル テクノロジー キキョウ抽出物の退行性脳疾患の予防および治療、または記憶力増進のための使用
WO2006046674A1 (ja) * 2004-10-25 2006-05-04 Chugai Seiyaku Kabushiki Kaisha Ｃ型肝炎ウイルス感染症の予防および治療剤

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014193088A1 (ko) * 2013-05-31 2014-12-04 동국대학교 산학협력단 포도근 추출물 또는 이의 분획물을 유효성분으로 포함하는 c형 간염의 예방 또는 치료용 조성물
US10258662B2 (en) 2013-05-31 2019-04-16 Dongguk University Industry-Academic Cooperation Foundation Composition for preventing or treating hepatitis C including vitidis vinferae radix extract or fraction thereof as active ingredient
KR20160096967A (ko) 2015-02-06 2016-08-17 주식회사 웰파이토 도라지 발효물을 유효성분으로 포함하는 기관지질환, 면역증강 및 항비만 예방 효능의 건강차 조성물

Also Published As

Publication number Publication date
WO2010085091A3 (en) 2010-11-25
KR20100086923A (ko) 2010-08-02
JP2012515773A (ja) 2012-07-12
EP2389185A2 (en) 2011-11-30
CA2748942A1 (en) 2010-07-29
CN102264378A (zh) 2011-11-30
US20110274656A1 (en) 2011-11-10
WO2010085091A2 (en) 2010-07-29
AU2010207093A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
KR101162710B1 (ko) 도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물
WO2009125964A2 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
WO2010111935A1 (zh) 一种新的丹酚酸化合物l、其制备方法和用途
Feng et al. Chinese medicines as a resource for liver fibrosis treatment
WO2017133468A1 (zh) 白头翁皂苷类化合物作为ev71病毒抑制剂的用途
TW201138773A (en) Dosage regimens for HCV combination therapy
EP1585524A2 (en) The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
KR102187951B1 (ko) 녹각 영지버섯 추출물 및 퀘르세틴을 유효성분으로 포함하는 엡스타인 바 바이러스-양성 위암 치료용 약학적 조성물
JP4422685B2 (ja) 肝保護のためのピニトールまたはカイロイノシトールの使用
CN103880856B (zh) 没药烷型倍半萜类衍生物及其药物组合物和其在制药中的应用
CN109939119B (zh) 栀子苷在制备治疗多发性硬化症药物中的应用
CN100479825C (zh) 龙胆苦苷在制备抗病毒药物中的应用
CN102885841B (zh) 安石榴苷的应用
AU2007270386A1 (en) Prophylactic or therapeutic agent for viral disease
US20130302279A1 (en) Identification of natural plant extracts harboring anti-hepatitis c virus ns5b polymerase activity
JPH09241157A (ja) リソスペルメートｂ含有肝臓保護作用医薬組成物
CN106822152B (zh) 一种药物组合物及其应用
CN113855688A (zh) Vina-ginsenoside R18在制备抗登革病毒药物制剂中的应用
KR20230037083A (ko) 담팔수 추출물, 분획물 또는 이들 유래 페놀화합물을 유효성분으로 포함하는, 인플루엔자 바이러스 감염증 예방, 치료 또는 개선용 조성물
WO1996036346A1 (en) Water-soluble extract originating in feather cockscomb
JPH11209282A (ja) ベルゲニン及びその誘導体を有効成分とする肝機能改善剤
JP2021046366A (ja) センソ及びゴオウの医薬用途
KR101824329B1 (ko) 목단피 추출물의 분획물을 포함하는 간질환의 예방 또는 치료용 조성물
KR102694541B1 (ko) 플로로탄닌을 유효성분으로 포함하는 항바이러스제
CN110536690B (zh) 用于预防或治疗丙型肝炎病毒感染疾病的药学组合物

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20150624

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20160624

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20170629

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20170629

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000